Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-135,500
Closed -$28.8M 138
2021
Q3
$28.8M Buy
135,500
+500
+0.4% +$115K 0.7% 48
2021
Q2
$32.9M Sell
135,000
-2,100
-2% -$517K 0.76% 47
2021
Q1
$34.1M Sell
137,100
-7,200
-5% -$1.72M 0.82% 45
2020
Q4
$33.2M Sell
144,300
-3,500
-2% -$807K 0.82% 46
2020
Q3
$37.6M Buy
+147,800
New +$36.6M 1.03% 41

Other funds holding AMGN

Homestead Advisers's AMGN Position: Q4 2021 in Review

Homestead Advisers sold out of Amgen (AMGN) in Q4 2021, closing a stake of 135,500 shares — an estimated $28.8M sold.

Homestead Advisers first reported a position in AMGN in Q3 2020 and held it in 5 quarters. The position peaked at $37.6M in Q3 2020. 2,293 funds tracked by Wall St. Rank hold AMGN as of Q4 2021.

  • Homestead Advisers reported no remaining Amgen position as of Q4 2021 after selling out during the quarter.
  • Homestead Advisers sold 135,500 Amgen shares in Q4 2021, an estimated $28.8M.
  • Homestead Advisers first reported a position in Amgen in Q3 2020 and held it in 5 quarters.
  • Homestead Advisers's Amgen position peaked at $37.6M in Q3 2020.
  • 2,293 funds tracked by Wall St. Rank held Amgen as of Q4 2021.

Based on Homestead Advisers's 13F filing for Q4 2021, filed 7 Feb 2022.